| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pediatric Sciences, University of Torino (L.d.S., D.R., L.S.), Torino; Department of Pediatrics and Neonatology, ASL6 (S.V.), Ciriè (Torino); and Division of Pediatric Endocrinology, Regina Margherita Childrens Hospital (M.R.A., C.d.S.), Torino, Italy
Address all correspondence and requests for reprints to: Dr. Luisa de Sanctis, Department of Pediatric Sciences, University of Torino, Piazza Polonia 94, Torino 10126, Italy. E-mail: ldesanct{at}pediatria.unito.it.
| Abstract |
|---|
|
|
|---|
-subunit of the stimulatory G protein (Gs
). It has been reported in 70% of PHP subjects from routine radiological examinations, but there are no specific data for hand alterations in genetically characterized PHP-Ia subjects. We evaluated the metacarpophalangeal pattern profile in 14 GNAS-mutated PHP-Ia subjects and determined the prevalence and patterns of left hand bone shortening. To search for genotype/phenotype correlations, we compared metacarpophalangeal pattern profiles in subjects with identical mutations. Shortening below 2 SD score (SDS) was present in at least one bone in each subject, with a prevalence of 100%; however, great variability existed between subjects and between hand bone segments. Between subjects, shortening ranged from 2 to 10.4 SDS and involved 119 hand bones (5.3100%). Between segments, IIIIV metacarpals were the most compromised (10.4 and 10.0 SDS, respectively); V metacarpals and IIV distal phalanges were the most frequently shortened (85.7%). Overall, bone length median values revealed shortening below 2 SDS in all metacarpals and all distal phalanges, i.e. brachymetacarpia and brachytelephalangy, that cluster together. These segments were shortened in 64.385.7% of patients, significantly differing from proximal and middle phalanges, which were shortened in 21.450%. Even if these hand alterations were a constant and typical finding in our PHP-Ia population, cluster analysis in subjects with the same genotypes did not generally show a genotype/phenotype correlation. Variability between subjects may be the result of complex interactions between GNAS defects and other genetic or epigenetic factors. In conclusion, hand shortening analysis in 14 genetically characterized patients showed typical brachymetacarpia and brachytelephalangy. Further studies in PHP-Ia subjects without GNAS mutations and in other brachydactyly syndromes will determine whether the pattern described is also specific. | Introduction |
|---|
|
|
|---|
PHP-Ia is caused by dominant mutations in the guanine nucleotide-binding protein
-stimulating polypeptide (GNAS) gene that encodes for Gs
protein. Subjects show Gs
protein deficiency and resistance to hormones that act through Gs
activation via the cAMP-adenylyl cyclase pathway (i.e. PTH, TSH, and FSH/LH) and AHO (6, 7, 8, 9, 10, 11, 12, 13). Gs
protein deficiency and GNAS mutations have also been identified in patients with isolated AHO phenotype, a clinical disorder called pseudopseudohypoparathyroidism (PPHP) (14, 15). A single GNAS mutation can be responsible for both PHP-Ia and PPHP in the same family when inherited from the maternal and paternal alleles, respectively. This has suggested that other genetic factors, such as genomic imprinting, may influence endocrine function (16, 17, 18). Among PHP-Ia/PPHP patients, AHO expression, too, varies greatly, as some subjects with GNAS mutations show few of its features (12, 19). The typical brachydactyly has been reported in 70% of PHP by routine radiological examinations (1).
The metacarpophalangeal pattern profile (MPP) introduced by Poznanski et al. (20) is an analytical tool for evaluating significant absolute and relative differences in the lengths of hand bones. It has been used to identify brachydactyly and to compare hand bone shortening in several disorders, such as PHP and PPHP, brachydactyly type E, Turners syndrome, and acrodysostosis (21, 22). There are no specific data for hand alterations in genetically characterized PHP-Ia patients.
In the present study we evaluated the prevalence and the entity of length shortening in the left hand bones of 14 GNAS-characterized PHP-Ia subjects. To search for genotype/phenotype correlation, MPPs from subjects harboring identical mutations, either in the same family or unrelated, were compared.
| Subjects and Methods |
|---|
|
|
|---|
Fourteen genetically characterized PHP-Ia subjects, five males and nine females, aged 426 yr, from 13 families (patients 8 and 9 are dizygotic twins) were included (Table 1
). Informed consent was obtained from all patients or their families.
|
To evaluate the presence of a genotype/phenotype correlation, MPPs from subjects with identical mutations, either from the same family or unrelated, were compared. Left hand radiographs were also obtained from the mothers of patients 3, 79, and 11, where c.344C
T, c.366delC, c.555delC and c.565_568delGACT mutations were identified, respectively, and PPHP was diagnosed by the presence of an isolated AHO phenotype. The subjects hand pattern profiles were constructed and compared with those of their mutated offspring. Moreover, MPPs from cases 1012, harboring the c.565_568delGACT mutation, were compared.
Hierarchical cluster analysis was used to cluster individuals and variables (23, 24, 25). Euclidean quadratic distance was used to estimate similarity between bones and product-moment correlation between subjects, using average linkage between groups (see the supplemental data published on The Endocrine Societys Journals Online web site at http://jcem.endojournals.org). Differences between proportions were tested by Fishers exact test (
= 0.05) (26). SPSS 9.0 (http://www.spss.com) was used to store, compute, and analyze data.
Molecular analysis
GNAS gene analysis was performed on genomic DNA isolated from peripheral blood leukocytes with the phenol/chloroform method. Exons 113, corresponding to the whole GNAS-coding sequence, and intron/exon boundaries were amplified by using 13 pairs of previously described GNAS-specific primers (12, 19, 27). Gel-purified fragments obtained with the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA) were directly sequenced with a semiautomated detection system (ABI 373A sequencer, PE Applied Biosystems, Foster City, CA). DNA sequence abnormalities were confirmed by restriction analysis of genomic PCR products with the appropriate endonucleases. The same technique was used to trace segregation of the mutation in the available subjects of each family and to test 5055 unrelated normal individuals (27).
GNAS causal mutations in 12 of 14 subjects have been previously described (27). In the remaining two patients GNAS gene analysis identified two new causal mutations. The first, c.348_349insT, is a single base insertion at codon 115 in exon 5 identified in patient 6 (Table 1
), who showed resistance to PTH and TSH, as well as several AHO clinical signs (obesity, rounded face, and mental retardation). It causes a frameshift with the creation of a premature stop codon after 22 codons. The second, c.861_862delTG, is a TG deletion at codon 287 in exon 11 identified in heterozygosis in patient 13 (Table 1
), who had resistance to PTH and TSH associated with AHO signs (brachydactyly, obesity, rounded face, and mental retardation). It causes a frameshift with the creation of a premature stop codon after 11 codons.
| Results |
|---|
|
|
|---|
Shortening below 2 SDS was found in 152 of 266 bones (57.1%), and each subject showed one or more shortened bones (Table 2
).
|
Overall, bone length median values in the 14 patients revealed shortening below 2 SDS in all metacarpals and all distal phalanges, i.e. brachymetacarpia and brachytelephalangy. Good correlations were observed for metacarpals (r ranging from 0.700.91) and distal phalanges (r ranging from 0.680.95) only (Fig. 1
; matrix correlations not shown).
|
MPPs from patients 3, 79, and 11 and their mothers, harboring c.344C
T, c.366delC, c.555delC and c.565_568-delGACT mutations, respectively (Figs. 2
and 4
), and MPPs from cases 1012 from different families and harboring the c.565_568delGACT mutation (Figs. 3
and 4
) were considered. Pattern profile comparison in subjects harboring c.344C
T and c.366delC mutations with their mutated mothers showed significant dissimilarity, with product-moment correlations of 0.34 and 0.29, respectively (Fig. 2
, A and B, and Fig. 4
). Comparison in the family with c.555delC mutation identified in the dizygotic twins and their mother demonstrated mild similarities between the siblings (r = 0.45), in contrast to dissimilarities in parent to child pattern profiles (r = 0.24 and 0.04 for patients 8 and 9 with their mother, respectively; Figs. 2C
and 4
). On the other hand, in patient 11 with the c.565_568delGACT mutation and his mutated mother, the profile similarity was considerable, with an r of 0.90 (Figs. 2D
and 4
). The c.565_568delGACT mutation displayed by subjects from different families was associated with similar MPP for patient 10 vs. patient 12 and for patient 11 vs. patient 12 (r = 0.41 and 0.45, respectively), but with dissimilar patterns for patient 10 vs. patient 11 (r = 0.09; Figs. 3
and 4
).
|
|
|
| Discussion |
|---|
|
|
|---|
In this study GNAS gene analysis allowed identification of the causal mutation and characterization of the PHP-Ia subtype in 14 AHO patients resistant to PTH, TSH, and FSH/LH. Therefore, we decided to analyze MPPs in this genetically defined subset of patients to determine whether GNAS mutations have typical and specific effects on skeletal phenotype.
Clinical or routine radiological examinations demonstrated brachydactyly in 11 of 14 patients (78.5%), and MMP analysis revealed a significant shortening below 2 SDS of one or more bones in all subjects.
There were great differences in hand shortening: some subjects displayed severe shortening (even reaching 10.4, 10.0, 9.3 and 9.2 SDS) of all hand bones (i.e. patients 10, 12, and 14), a finding similar to that described in acrodysostosis (21), whereas others had shortening below 2 SDS for only one or a few bones (i.e. patients 9 and 6). Shortening prevalence below 2 SDS ranged from 5.3100% of the bones. Shortening of the hand segments also varied greatly, both in severity, where metacarpals were the most impaired, and in prevalence, where the metacarpals and distal phalanges group was shortened in 64.385.7% of cases, and the proximal and middle phalanges group was shortened in 21.450.0% of cases.
Median z-scores indicated shortening below 2 SDS in all metacarpals (ranging from 2.0 to 3.5 SDS) and all distal phalanges (ranging from 2.6 to 4.5 SDS), not only in the classically reported III, IV, and V metacarpals and the I distal phalanx (1, 21). The V metacarpal and IIV distal phalanges were the most frequently affected (85.7%), with no differences in shortening prevalence, whereas data in PHP patients have previously shown 75% prevalence for the I distal phalanx and 65% for the IV metacarpal (21). This pattern profile was both a typical and constant finding, as in subjects with milder hand involvement (patients 9 and 6), metacarpals and distal phalanges are relatively more impaired than other segments. Thus, brachymetacarpia, which denotes shortening of the metacarpals, and brachytelephalangy, which denotes shortening of the distal phalanges, characterized the hands of the 14 PHP-Ia subjects.
As in PHP/PPHP subjects brachydactyly has been described as a progressive sign (20), and our patients included both adults as well as children, even aged 4 or 5 yr, we looked for significant age-related differences. In the younger subjects (patients 1, 2, 4, 6, 7, 12, and 13), in whom brachydactyly could be not fully established because final height had not been reached, shortening was always evident, ranging from severe and involving all hand segments (patient 12) to mild (patient 6). The great variability observed in the adult group was also present in the younger patients. In subjects with mild shortening (patients 6 and 13), MPP analysis showed the same pattern profile as in the other subjects, with relatively major impairment of metacarpals and distal phalanges. In these patients, hand involvement could be progressive and thus worsen the already typical profile.
No significant MPP differences were observed between the sexes.
As hand shortening was constant in our patients, we evaluated whether the variability between subjects and between segments could be related to individual GNAS mutations, i.e. whether same genotypes correlated with specific skeletal abnormalities. Cluster analysis, used to compare the type of hand shortening in subjects with the same mutations from the same family or unrelated subjects, revealed that they did not generally display greatly similar patterns, indicating that each mutation was unlikely to be responsible for a specific MPP alteration. Thus, even if GNAS mutations seem both necessary and sufficient to produce the specific bone length alterations, a genotype/phenotype correlation cannot be determined by considering shortening as a phenotypic marker. MPP variability is probably the result of complex interactions between GNAS gene defects and other genetic or epigenetic factors.
In conclusion, the molecular characterization of the PHP-Ia condition in 14 patients allowed exploration of the phenotype relationship. Hand shortening evaluation with MPP analysis showed typical brachymetacarpia and brachytelephalangy, i.e. absolute or relative shortening of the metacarpals and distal phalanges in the 14 PHP-Ia patients. Brachydactyly assessment with formal MPP analysis should therefore be considered when PHP-Ia is suspected, as it is the only reliable way to disclose this typical pattern. However, as up to 30% of patients with clinically confirmed PHP-Ia do not have GNAS mutations (13, 27), it would be interesting to evaluate MPPs in these subjects as well as in other genetically defined brachydactyly syndromes to elucidate whether the pattern described in GNAS-mutated PHP-Ia subjects is also specific.
| Footnotes |
|---|
-stimulating polypeptide; MPP, metacarpophalangeal pattern profile; PHP-Ia, pseudohypoparathyroidism type Ia; PPHP, pseudopseudohypoparathyroidism; SDS, SD score. Received May 16, 2003.
Accepted January 8, 2004.
| References |
|---|
|
|
|---|
gene. Proc Natl Acad Sci USA 85:20812085
subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy. Proc Natl Acad Sci USA 85:617621
-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA 87:82878290
-subunit of the guanine nucleotide-binding protein Gs in pseudo- and pseudopseudohypoparathyroidism. J Clin Endocrinol Metab 83:935938
subunit (Gs
) knockout mice is due to tissue-specific imprinting of the Gs
gene. Proc Natl Acad Sci USA 95:87158720
subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy. J Clin Endocrinol Metab 75:171184
This article has been cited by other articles:
![]() |
A.-S. Balavoine, M. Ladsous, F.-L. Velayoudom, V. Vlaeminck, C. Cardot-Bauters, M. d'Herbomez, and J.-L. Wemeau Hypothyroidism in patients with pseudohypoparathyroidism type Ia: clinical evidence of resistance to TSH and TRH Eur. J. Endocrinol., October 1, 2008; 159(4): 431 - 437. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |